Transcriptional regulation of the CYP2B1 and CYP2B2 genes by C/EBP-related proteins

Biochemical Pharmacology

Volumn 51, Issue 3, 1996, Pages 345-356

  Luc, Phuong Van T ^a   Adesnik, Milton ^a   Ganguly, Sabya ^a   Shaw, Peter M ^a,b  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b INVITROGEN CORPORATION   (United States)

Author keywords

C EBP ; CYP2B1; CYP2B2; cytochrome P450; gene; promoter; transcription

Indexed keywords

CYTOCHROME P450 ISOENZYME; DEOXYRIBONUCLEASE I; OLIGONUCLEOTIDE; PHENOBARBITAL;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BINDING SITE; CONTROLLED STUDY; DNA FOOTPRINTING; GENE CONTROL; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; INTRAPERITONEAL DRUG ADMINISTRATION; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; RECOMBINANT DNA TECHNOLOGY;

EID: 0030019412     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/0006-2952(95)02190-6     Document Type: Article

References (44)

1. Atchison M and Adesnik M, Genes for cytochrome P-450 and their regulation. CRC Crit Rev Biochem 19: 247-305, 1986.
2. Guengerich FP, Mammalian cytochromes P450. Prog Drug Metab 10: 1-54, 1987.
3. Gonzalez FJ, The molecular biology of cytochrome P450s. Pharmacol Rev 40: 243-288, 1988.
4. Nelson DR, Kamataki T, Waxman DJ, Guengerich FP, Estabrook RE, Feyereisen R, Gonzalez FJ, Coon MJ, Gunsales IC, Gotoh O, Okuda K and Nebert DW, The P450 superfamily: Update on new sequences, gene mapping, accession numbers, early trivial names of enzymes, and nomenclature. DNA Cell Biol 12: 1-51, 1993.
5. Shaw PM, Transcriptional regulation of drug metabolizing enzymes in the liver. In: Liver Gene Expression (Eds. Tronche F and Yaniv M), pp. 87-111. R. G. Landes Co., Austin, TX, 1994.
6. Gonzalez FJ, Kimura S, Song BJ, Pastewka J, Gelboin HV and Hardwick JP, Sequence of two related P-450 mRNAs transcriptionally increased during rat development. J Biol Chem 261: 10667-10672, 1986.
7. Hardwick J, Gonzalez FJ and Kasper CB, Transcriptional regulation of rat liver epoxide hydratase, NADPH-cytochrome P450 oxidoreductase and cytochrome P450 genes by phenobarbital. J Biol Chem 258: 8081-8085, 1983.
8. De Simone V and Cortese R, Transcriptional regulation of liver-specific gene expression. Curr Opin Cell Biology 3: 960-965, 1991.
9. Sladek FM and Darnell JE, Mechanisms of liver-specific gene expression. Curr Opin Gen Dev 2: 256-259, 1992.
10. Swanson HI and Bradfield CA, The Ah-receptor: Genetics, structure and function. Pharmacogenetics 3: 213-230, 1993.
11. Waxman DJ and Azaroff L, Phenobarbital induction of cytochrome P450 gene expression. Biochem J 281: 577-592, 1992.
12. Atchison M and Adesnik M, A cytochrome P-450 multigene family. J Biol Chem 258: 11285-11295, 1983.
13. Pike SF, Shephard EA, Rabin BR and Phillips IR, Induction of cytochrome P-450 by phenobarbital is mediated at the level of transcription. Biochem Pharmacol 34: 2489-2494, 1985.
14. Rangarajan PN and Padmanaban G, Regulation of cytochrome P-450b/e gene expression by a heme-and phenobarbitone-modulated transcription factor. Proc Natl Acad Sci USA 86: 3963-3967, 1989.
15. He J-S and Fulco AJ, A barbituate-regulated protein binding to a common sequence in the cytochrome P450 genes of rodents and bacteria. J Biol Chem 266: 7864-7869, 1991.
16. Hoffmann M, Mager WH, Scholte BJ, Civil A and Planta R, Analysis of the promoter of the cytochrome P-450 2B2 gene in the rat. Gene Expression 2: 353-362, 1992.
17. Shephard E, Forrest LA, Shervington A, Fernandez LM, Ciaramella G and Philips IR, Interaction of proteins with a cytochrome P450 2B2 gene promoter: Identification of two DNA sequences that bind proteins that are enriched or activated in response to phenobarbital. DNA Cell Biol 13: 793-804, 1994.
18. Hemenway C and Robins DM, DNase I-hypersensitive sites associated with expression and hormonal regulation of mouse C4 and Slp genes. Proc Natl Acad Sci USA 84: 4816-4820, 1987.
19. Becker PB, Gloss B, Schmid W, Strahle U and Schutz G, In vivo protein-DNA interactions in a glucocorticoid response element require the presence of hormone. Nature 324: 686-688, 1986.
20. Church GM and Gilbert W, Genomic sequencing. Proc Natl Acad Sci USA 81: 1991-1995, 1984.
21. Gorski K, Carneiro M and Schibler U, Tissue-specific in vitro transcription from the mouse albumin promoter. Cell 47: 767-776, 1986.
22. Sambrook J, Fritsch EF and Maniatis T, Molecular Cloning: A Laboratory Manual, 2nd Edn. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, 1989.
23. Metz R and Ziff E, The helix-loop-helix protein rE12 and the C/EBP-related factor rNFIL-6 bind to neighboring sites within the c-fos serum response element. Oncogene 6: 2165-2176, 1991.
24. Shaw PM, Weiss MC and Adesnik M, Hepatocyte nuclear factor 3 is a major determinant of CYP2C6 promoter activity in hepatoma cells. Mol Pharmacol 46: 79-87, 1994.
25. Shaw PM, Adesnik M, Weiss MC and Corcos L, The phenobarbital-induced transcriptional activation of cytochrome P-450 genes is blocked by the glucocorticoid-progesterone antagonist RU-486. Mol Pharmacol 44: 775-783, 1993.
26. Luckow B and Schutz G, CAT constructions with multiple unique restriction sites for the functional analysis of eucaryotic promoters and regulatory elements. Nucleic Acids Res 15: 5490, 1987.
27. Rivkin E, Definition, Structure and Regulation of a Cytochrome P-450 Transcription Unit, Ph.D. Thesis. Basic Medical Sciences Program, New York University, 1985.
28. Jaiswal AK, Rivkin E and Adesnik M, 5′-Flanking sequence of the gene for rat hepatic cytochrome P450e. Nucleic Acids Res 15: 6755, 1987.
29. Metz R and Ziff E, cAMP stimulates the C/EBP-related transcription factor rNFIL-6 to translocate to the nucleus and induce c-fos transcription. Genes Dev 5: 1754-1766, 1991.
30. Johnson PF and Williams SC, CCAAT/enhancer binding (C/ EBP) proteins. In: Liver Gene Expression (Eds. Tronche F and Yaniv M), pp. 231-258. R. G. Landes Co., Austin, TX, 1994.
31. Angrand P-O, Kallenbach S, Weiss MC and Rousset J-P, An exogenous albumin promoter can become silent in dedifferentiated hepatoma variants as well as intertypic hybrids. Cell Growth Differ 1: 519-526, 1990.
32. Auesbperg N, Long-term cultivation of hypodiploid human tumor cells. J Natl Cancer Inst 32: 135-148, 1964.
33. Aden DP, Fogel A, Plotkin S, Damjanov I and Knowles B, Controlled synthesis of HBsAG in a differentiated liver carcinoma-derived cell line. Nature 282: 615-616, 1979.
34. Waxman DJ, Morrisey JJ, Naik S and Jauregui HO, Phenobarbital induction of cytochromes P-450. Biochem J 271: 113-119, 1990.
35. Trottier E, Belzil A, Stoltz C and Anderson A, Localization of a phenobarbital-responsive element (PBRE) in the 5′-flanking region of the rat CYP2B2 gene. Gene 158: 263-268, 1995.
36. Ramsden R, Sommer KM and Omiecinski CJ, Phenobarbital induction and tissue-specific expression of the rat CYP2B2 gene in transgenic mice. J Biol Chem 268: 21722-21726, 1993.
37. Lee Y-H, Yano M, Liu S-Y, Matsunaga E, Johnson PF and Gonzalez FJ, A novel cis-acting element controlling the rat CYP2D5 gene and requiring cooperativity between C/EBPβ and an Sp1 factor. Mol Cell Biol 14: 1383-1394, 1994.
38. Yano M, Falvey E and Gonzalez FJ, Role of the liver-enriched transcription factor DBP in expression of the cytochrome P450 CYP2C6 gene. Mol Cell Biol 12: 2847-2854, 1992.
39. van Ooij C, Snyder RC, Paeper BW and Duester G, Temporal expression of the human alcohol dehydrogenase gene family during liver development correlates with differential promoter activation by hepatocyte nuclear factor 1, CCAAT/enhancer-binding protein α, liver activator protein, and D-element-binding protein. Mol Cell Biol 12: 3023-3031, 1992.
40. Williams JF, Bernent W, Sinclair J and Sinclair P, Effect of interleukin 6 on phenobarbital induction of cytochrome P-450IIB in cultured hepatocytes. Biochem Biophys Res Commun 178: 1049-1055, 1991.
41. Clark MA, Bing BA, Gottschall PE and Williams JF, Differential effect of cytokines on the phenobarbital or 3-methylcholanthrene induction of P450 mediated monooxygenase activity in cultured rat hepatocytes. Biochem Pharmacol 49: 97-104, 1995.
42. Poli V and Ciliberto G, Transcriptional regulation of acute phase genes by IL-6 and related cytokines. In: Liver Gene Expression (Eds. Tronche F and Yaniv M), pp. 131-151. R. G. Landes Co., Austin, TX, 1994.
43. Mischoulon D, Rana B, Bucher NL and Farmer SR, Growth-dependent inhibition of CCAATT enhancer binding protein (C/ EBPα) gene expression during hepatocyte proliferation in the regenerating liver and in culture. Mol Cell Biol 12: 2553-2560, 1992.
44. Umek RM, Friedman AD and McKnight SL, CCAAT-enhancer binding protein: A component of a differentiation switch. Science 251: 288-292, 1991.